Literature DB >> 19824986

Illicit substance use and its correlates in first episode psychosis.

R Mazzoncini1, K Donoghue, J Hart, C Morgan, G A Doody, P Dazzan, P B Jones, K Morgan, R M Murray, P Fearon.   

Abstract

OBJECTIVE: To determine if substance use (particularly cannabis) is more frequent among first episode psychosis patients and associated with a more problematic clinical presentation.
METHOD: All first episode psychosis (FEP) patients presenting to secondary services were recruited from London and Nottingham, over 2 years, in the Aetiology and Ethnicity of Schizophrenia and Other Psychoses study broad framework. Clinical and sociodemographic variables were assessed using a set of standardized instruments. A schedule was created to retrospectively collate substance use data from patients, relatives and clinicians.
RESULTS: Five hundred and eleven FEP were identified. They used three to five times more substances than general population. Substance use was associated with poorer social adjustment and a more acute mode of onset. Cannabis use did not affect social adjustment, but was associated with a more acute mode of onset.
CONCLUSION: Cannabis has a different impact on FEP than other substances. Large epidemiological studies are needed to disentangle cannabis effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19824986     DOI: 10.1111/j.1600-0447.2009.01483.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  12 in total

1.  Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis.

Authors:  Michael T Compton; Beth Broussard; Claire E Ramsay; Tarianna Stewart
Journal:  Schizophr Res       Date:  2010-10-30       Impact factor: 4.939

2.  Persistent cannabis use among young adults with early psychosis receiving coordinated specialty care in the United States.

Authors:  Leslie Marino; Jennifer Scodes; Talia Richkin; Jean-Marie Alves-Bradford; Ilana Nossel; Melanie Wall; Lisa Dixon
Journal:  Schizophr Res       Date:  2020-05-28       Impact factor: 4.939

Review 3.  Cannabis in sport: anti-doping perspective.

Authors:  Marilyn A Huestis; Irene Mazzoni; Olivier Rabin
Journal:  Sports Med       Date:  2011-11-01       Impact factor: 11.136

4.  Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.

Authors:  Christian Núñez; Susana Ochoa; Elena Huerta-Ramos; Iris Baños; Ana Barajas; Montserrat Dolz; Bernardo Sánchez; Núria Del Cacho; Judith Usall
Journal:  Psychopharmacology (Berl)       Date:  2015-12-01       Impact factor: 4.530

5.  Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.

Authors:  Ruth Salo; Catherine Fassbender; Ana-Maria Iosif; Stefan Ursu; Martin H Leamon; Cameron Carter
Journal:  Psychiatry Res       Date:  2013-07-26       Impact factor: 3.222

Review 6.  Substance use in clinical high risk for psychosis: a review of the literature.

Authors:  Jean Addington; Nevicia Case; Majid M Saleem; Andrea M Auther; Barbara A Cornblatt; Kristin S Cadenhead
Journal:  Early Interv Psychiatry       Date:  2013-11-14       Impact factor: 2.732

7.  Pathways from victimization to substance use: Post traumatic stress disorder as a mediator.

Authors:  Jung Yeon Lee; Judith S Brook; Stephen J Finch; David W Brook
Journal:  Psychiatry Res       Date:  2016-01-22       Impact factor: 3.222

8.  Developing a theoretical framework for persistent cannabis use among young adults with first episode psychosis.

Authors:  Leslie Marino; Samantha E Jankowski; Rick Kent; Michael L Birnbaum; Ilana Nossel; Jean-Marie Alves-Bradford; Lisa Dixon
Journal:  Early Interv Psychiatry       Date:  2021-05-16       Impact factor: 2.732

Review 9.  Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses.

Authors:  James B Kirkbride; Antonia Errazuriz; Tim J Croudace; Craig Morgan; Daniel Jackson; Jane Boydell; Robin M Murray; Peter B Jones
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

Review 10.  Non-Genetic Factors in Schizophrenia.

Authors:  Simona A Stilo; Robin M Murray
Journal:  Curr Psychiatry Rep       Date:  2019-09-14       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.